Cowan Elvia sold PCVX
April 7, 2026 · Form 4 insider transaction
Cowan Elvia sold 3,000 shares of Vaxcyte, Inc. at $60.00 per share, a transaction worth $180.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3,000
Price
$60.00
Total value
$180.0K
InsiderCowan Elvia
RoleOfficer
CompanyVaxcyte, Inc. (PCVX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 7, 2026
Filing dateApril 8, 2026
Shares owned after28,975
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025.